Effects of Chios mastic gum on cardiometabolic risk factors |
| |
Authors: | Athanasia K Papazafiropoulou |
| |
Affiliation: | Athanasia K Papazafiropoulou, The First Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, Piraeus 18536, Greece |
| |
Abstract: | Chios mastic gum (CMG), the resin produced by the trunk of Pistachia lentiscus var Chia, has been used for culinary and medicinal purposes since antiquity. Despite the fact that Pistacia species are widely distributed throughout the Mediterranean basin and in the circum-Mediterranean regions, CMG is a distinctive resin of the mastic trees grown exclusively in the southern part of the island of Chios. CMG has been used for centuries as a spice, a cosmetic, but its most important usage has been as a strong phytotherapeutic therapy, primarily for the management of gastrointestinal diseases. Recently, there are studies demonstrating that CMG has hypolipidemic, cardioprotective and antidiabetic properties. Therefore, the aim of the present review is to summarize the existing literature data regarding the potential beneficial effects of CMG on cardio-metabolic risk factors. |
| |
Keywords: | Chios mastic gum Glucose Cardioprotection Low-density lipoprotein-cholesterol Triglycerides |
|
| 点击此处可从《World journal of diabetes》浏览原始摘要信息 |
|